SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?SARS-CoV-2-토착 미생물총 넥서스: 장내 미생물총이 COVID-19의 염증 및 질병 중증도에 기여합니까?Cellular and Infection Microbiology Published on 2021-03-112022-09-11 Journal: Frontiers in Cellular and Infection Microbiology [Category] SARS, 유전자 메커니즘, [키워드] ACE2 alteration approach Asymptomatic COVID-19 Cardiovascular disorders Clinical outcome co-morbidities comorbid condition contribute COVID-19 COVID-19 disease disease Dysbiosis effective Gut gut microbiome gut microbiota Host immune responses Immunopathogenesis Inflammation innate immune response Microbiome Microbiota (microorganism) morbidities novel obesity prebiotics prediction Probiotics profile SARS-CoV-2 SARS-CoV-2 (2019-nCoV) SARS-COV-2 infection symptomatic T2D targeted intervention targeted interventions Therapeutic approach Therapeutic strategies [DOI] 10.3389/fcimb.2021.590874 PMC 바로가기 [Article Type] Cellular and Infection Microbiology
A novel rationale for targeting FXI: Insights from the hemostatic microRNA targetome for emerging anticoagulant strategiesReview article Published on 2021-02-012022-10-05 Journal: Pharmacology & therapeutics [Category] 비임상, [키워드] activities antagonist Anticoagulant applicability approaches bleeding Blood coagulation Cardiovascular disorders changed coagulation factor Comorbidity components DOACs Efficacy and safety expression Factor functional Hemostasis IIa Inflammation insight interfere microRNA mimicking oral anticoagulant overcome patients worldwide replaced RNA therapeutics therapeutic therapeutic option Therapeutic strategies therapeutic targeting Thromboembolism thrombosis Traditional Treatment Venous Thromboembolism without affecting [DOI] 10.1016/j.pharmthera.2020.107676 [Article Type] Review article
The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19Review Published on 2021-01-222023-06-15 Journal: Molecular biology reports [Category] MERS, [키워드] Cardiovascular disorders COVID-19 Hs-cTnI NT-proBNP Prognosis [DOI] 10.1007/s11033-021-06148-9 PMC 바로가기 [Article Type] Review
Exercise, Immune System, Nutrition, Respiratory and Cardiovascular Diseases during COVID-19: A Complex CombinationReview Published on 2021-01-212022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, [키워드] absence acute respiratory syndrome cardiovascular cardiovascular diseases Cardiovascular disorders coronavirus CoV CoVs defend disease evade exercise function Health Host humans immune immune response immune system infect Interaction nutrition physical activity Physical exercise provide replicate respiratory respiratory infection RNA virus System [DOI] 10.3390/ijerph18030904 PMC 바로가기 [Article Type] Review
Challenge of post-COVID era: management of cardiovascular complications in asymptomatic carriers of SARS-CoV-2Article Published on 2021-01-112023-06-14 Journal: Heart failure reviews [Category] MERS, SARS, [키워드] ACE-2 asymptomatic patients Cardiovascular disorders COVID-19 SARS-CoV-2 [DOI] 10.1007/s10741-021-10076-y PMC 바로가기 [Article Type] Article
Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential TreatmentsPharmacology Published on 2020-10-292022-10-31 Journal: Frontiers in Pharmacology [Category] COVID-19, [키워드] ACE2 acute respiratory distress acute respiratory syndrome angiotensin-converting enzyme 2 appear ARDS binding Cardiovascular disorders Cell consequence coronavirus coronavirus disease Coronavirus-2 Coronaviruses COVID-19 COVID-19 pathogenesis death develop disease endocytic endocytosed endocytosis endolysosome endosome feature Genome Host host protein Human immunological responses infect cell infected with SARS-CoV-2 Potential priming protease replication site respiratory restrict role SARS-CoV-2 SARS-COV-2 infection serine 2 single-stranded RNA virus Symptom syndrome target therapeutic strategy TMPRSS2 transmembrane two pore channel viral spike protein virus virus entry viruses [DOI] 10.3389/fphar.2020.595888 PMC 바로가기 [Article Type] Pharmacology
Managing the combined consequences of COVID-19 infection and lock-down policies on athletes: narrative review and guidelines proposal for a safe return to sportReview Published on 2020-10-192022-10-27 Journal: BMJ Open Sport — Exercise Medicine [Category] COVID-19, [키워드] affected appear approach biological profile cardiac complication Cardiology Cardiovascular disorders clinical manifestation Community consequence cough COVID-19 COVID-19 infection COVID-19 pandemic diabete disease spread Dyspnoea evaluate exercise fatigue Fever globe headache Health hypertension hypoxaemia individual individuals managing Medical conditions MONITOR multiorgan failure myalgia myocarditis occur physical ability Physiology Postinfection reduce reported respiratory Respiratory failure risk Safe severe cases Shock sore throat sports & exercise medicine stoppage Symptom Symptoms symptoms of COVID-19 the disease [DOI] 10.1136/bmjsem-2020-000849 PMC 바로가기 [Article Type] Review
Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?Review Published on 2020-10-052023-06-15 Journal: Pharmacology & therapeutics [Category] MERS, [키워드] AA, arachidonic acid ACE, Angiotensin converting enzyme ALA, α-Linolenic acid ALI, Acute Lung Injury Ang, angiotensin ARB, Angiotensin II receptor blocker ARDS, acute respiratory distress syndrome bioactive metabolites Cardiovascular disorders COVID-19 COVID-19, Coronavirus disease 2019 COX, cyclooxygenase CRP, C-reactive protein CVD, cardiovascular disease CYP, Cytochrome P450 DHA, Docosahexaenoic acid EDP, Epoxydocosapentaenoic acid EEQ, Epoxyeicosatetraenoic acid EPA, eicosapentaenoic acid GPR, G-protein coupled receptor HDHA, Hydroxydocosahexaenoic acid HDL-c, High density lipoprotein cholesterol HF, heart failure ICU, Intensive care unit IFN, interferon IL, interleukin Inflammation LA, linoleic acid LOX, lipoxygenase LPS, lipopolysaccharide LT, Leukotriene MERS-CoV, Middle East respiratory syndrome-related coronavirus MI, myocardial infarction n-3 polyunsaturated fatty acids nCoVs, Novel coronaviruses NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells NLRP3, NOD, LRR and pyrin domains-containing protein 3 PG, prostaglandin PMN, Polymorphonuclear neutrophils PPAR, Peroxisome proliferator-activated receptor PUFA, Polyunsaturated fatty acid RAAS, Renin-angiotensin aldosterone system RNA, Ribonucleic acid ROS, reactive oxygen species SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 SARS-CoV, severe acute respiratory syndrome coronavirus SPM, Specialized pro-resolving mediators TLR, Toll-like receptor TNF-α, tumor necrosis factor-α TX, Thromboxane. [DOI] 10.1016/j.pharmthera.2020.107703 PMC 바로가기 [Article Type] Review
Thrombosis and COVID-19: The Potential Role of NutritionNutrition Published on 2020-09-252022-10-31 Journal: Frontiers in Nutrition [Category] COVID-19, [키워드] acute respiratory syndrome Affect Anticoagulants antiplatelet Antithrombotic Cardiomyopathy Cardiovascular disorders caused characterized complications condition Contagion coronavirus coronavirus disease COVID-19 Critical diabete disorders globe greater healthy implicated incidence Infection Inflammation Intensive involved neurological system Non-communicable disease nutraceuticals nutrition nutritional status obesity outcomes Patient physical Potential Prevent Prophylaxis reduce renal reported Research respiratory symptom responsible risk risk factor role SARS-CoV-2 Severe COVID-19 Infection Spread stroke syndrome the disease thrombosis thrombotic complication Thrombotic complications Treatment Vasculitis Venous thrombosis while [DOI] 10.3389/fnut.2020.583080 PMC 바로가기 [Article Type] Nutrition
Cardiovascular patients in COVID‐19 era, a case series, an experience from a tertiary cardiovascular center in Tehran, IranCase Report Published on 2020-07-232022-11-01 Journal: Clinical Case Reports [Category] COVID-19, [키워드] aortic dissection cardiovascular Cardiovascular disorders Case series coronavirus coronavirus disease COVID‐19 involved Iran Myocardial infarction myocarditis pathway Patient Tehran [DOI] 10.1002/ccr3.3163 PMC 바로가기 [Article Type] Case Report